You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Splenic Lymphoma

Showing 1 - 25 of 5,622
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)

Not yet recruiting
  • Splenic Marginal Zone Lymphoma
  • Aarhus, Denmark
  • +4 more
Feb 17, 2023

Recurrent Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Nodal Marginal Zone Lymphoma Trial (Acalabrutinib,

Withdrawn
  • Recurrent Follicular Lymphoma
  • +8 more
  • (no location specified)
Jun 2, 2022

Integrated Molecular and Clinical Profiling to Optimize Outcome

Completed
  • Splenic Marginal Zone Lymphoma
    • Bellinzona, Switzerland
      IOSI
    Jun 4, 2021

    CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,

    Terminated
    Has Results
    • Central Nervous System Lymphoma
    • +6 more
    • Akt/ERK Inhibitor ONC201
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 30, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +23 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 23, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

    Completed
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +8 more
    • PI3K inhibitor BKM120
    • +3 more
    • Atlanta, Georgia
    • +1 more
    Jun 27, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

    Active, not recruiting
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +9 more
    • BTK inhibitor PCI-32765
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    Jun 27, 2022

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    May 6, 2022

    Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

    Recruiting
    • Mantle Cell Lymphoma
    • +5 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 19, 2021

    Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

    Recruiting
    • Marginal Zone Lymphoma
    • +2 more
    • Yvoir, Belgium
    • +36 more
    Nov 4, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

    Active, not recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • Scottsdale, Arizona
    • +1 more
    Aug 10, 2021

    Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +18 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Mar 11, 2021

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +71 more
    • Chicago, Illinois
    • +5 more
    Oct 8, 2021

    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

    Terminated
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +116 more
    • brentuximab vedotin
    • +2 more
    • Chicago, Illinois
    • +2 more
    Aug 30, 2021

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

    Completed
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +88 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Apr 14, 2021

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +18 more
    • Scottsdale, Arizona
    • +1 more
    Sep 28, 2020

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +35 more
    • Akt inhibitor MK2206
    • laboratory biomarker analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 14, 2020

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +46 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 10, 2021

    Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Mature T-Cell and

    Completed
    Has Results
    • Anaplastic Large Cell Lymphoma
    • +12 more
    • Iowa City, Iowa
    • +1 more
    Apr 3, 2020

    Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

    Not yet recruiting
    • Marginal Zone Lymphoma
    • (no location specified)
    Nov 6, 2023

    Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,

    Completed
    • Cutaneous B-cell Non-Hodgkin Lymphoma
    • +15 more
    • dendritic cell vaccine therapy
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 13, 2020

    Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

    Recruiting
    • Hodgkin Lymphoma
    • +3 more
    • Stanford, California
      Stanford University
    Jun 21, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Stanford (biological, drug, radiation)

    Completed
    Has Results
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +6 more
    • Ipilimumab
    • +2 more
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 17, 2019